analyst valuations, page-16

i am not getting at anyone.

i got in at 21.5 cents the other day.

prr is not the only game in town.

it is not even my top pick.

it is risky buying oil and biotechs.

they may strike oil, but it may not be economic.

the drug may work, but it may not get fda approval.

imo the following are just as perspective as prr:

silver: ayn ccu ivr

uranium: acb ags era pen pdn toe usa

oil: bcc ssn

phosphate: lgdi nup

potash: pwn pok

copper: avb cdu

ree: ggg lyc pek

coal: afr ccc nmr zyl

once a share has dropped below the 30 day moving average, i'm usually out and will not buy back until imo it hits rock bottom.

i did that with ags ivr pen and nup and i think i am free carried / almost free carried by now???

i'm in the market for more or less 2.5 years, then i will be going prodominatily short, stick to quants and etf's.